Vinay Jain

7.6k total citations · 2 hit papers
192 papers, 5.7k citations indexed

About

Vinay Jain is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Vinay Jain has authored 192 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 34 papers in Molecular Biology. Recurrent topics in Vinay Jain's work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Lung Cancer Treatments and Mutations (15 papers). Vinay Jain is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Lung Cancer Treatments and Mutations (15 papers). Vinay Jain collaborates with scholars based in India, United States and China. Vinay Jain's co-authors include Beena Rai, Dharmendr Kumar, A.J. Grillo-López, M. S. Czuczman, Christine A. White, Diying Shen, Michael E. Williams, Ronald Levy, B.K. Dallaire and Isabelle Bence‐Bruckler and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vinay Jain

177 papers receiving 5.5k citations

Hit Papers

Rituximab chimeric anti-CD20 monoclonal antibody therapy ... 1998 2026 2007 2016 1998 2002 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinay Jain India 29 2.3k 1.7k 1.6k 1.3k 1.2k 192 5.7k
Joseph M. Flynn United States 31 1.9k 0.8× 2.4k 1.4× 1.0k 0.6× 313 0.2× 1.1k 0.9× 119 4.9k
Eiichi Tanaka Japan 47 657 0.3× 579 0.3× 2.2k 1.4× 1.2k 0.9× 562 0.5× 424 12.9k
Sung‐Bae Kim South Korea 54 827 0.4× 954 0.6× 10.1k 6.5× 3.5k 2.6× 1.0k 0.8× 438 17.0k
R. Fischer Germany 31 1.1k 0.5× 1.2k 0.7× 791 0.5× 273 0.2× 865 0.7× 204 4.2k
Wen Jiang China 55 352 0.2× 530 0.3× 2.7k 1.7× 521 0.4× 2.4k 2.0× 269 11.0k
Roman Hájek Czechia 50 755 0.3× 1.1k 0.7× 5.1k 3.2× 331 0.2× 950 0.8× 567 10.9k
Frank Berthold Germany 60 496 0.2× 2.1k 1.2× 2.9k 1.8× 420 0.3× 881 0.7× 320 16.4k
David M. Hyman United States 46 1.6k 0.7× 777 0.5× 4.7k 3.0× 704 0.5× 1.1k 0.9× 221 11.5k
Tae Min Kim South Korea 57 2.3k 1.0× 1.9k 1.1× 7.6k 4.8× 1.6k 1.2× 2.1k 1.7× 462 13.4k
Kyung Won Kim South Korea 53 502 0.2× 240 0.1× 2.7k 1.7× 2.8k 2.1× 279 0.2× 415 10.5k

Countries citing papers authored by Vinay Jain

Since Specialization
Citations

This map shows the geographic impact of Vinay Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinay Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinay Jain more than expected).

Fields of papers citing papers by Vinay Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinay Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinay Jain. The network helps show where Vinay Jain may publish in the future.

Co-authorship network of co-authors of Vinay Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Vinay Jain. A scholar is included among the top collaborators of Vinay Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinay Jain. Vinay Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oran, Betül, David Marin, Qaiser Bashir, et al.. (2024). Long-Term Follow-up of Crenolanib Maintenance after Allogeneic Transplantation in Newly Diagnosed and Relapsed FLT3 Mutated AML. Blood. 144(Supplement 1). 1497–1497. 1 indexed citations
2.
Aghazadeh, Marziyeh, et al.. (2024). Stem cells in regenerative dentistry: Current understanding and future directions. Journal of Oral Biosciences. 66(2). 288–299. 10 indexed citations
3.
Akram, Wasim, Tanweer Haider, Pankaj Sharma, et al.. (2024). Blockchain technology: A potential tool for the management of pharma supply chain. Research in Social and Administrative Pharmacy. 20(6). 156–164. 18 indexed citations
4.
Kumar, Dharmendr, et al.. (2024). Accelerating corrosion inhibitor discovery through computational routes: a case of naphthalene 1-thiocarboxamide. npj Materials Degradation. 8(1). 1 indexed citations
5.
Wang, Eunice S., Aaron D. Goldberg, Martin S. Tallman, et al.. (2024). Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of Clinical Oncology. 42(15). 1776–1787. 22 indexed citations
6.
Kumar, Dharmendr, Vinay Jain, & Beena Rai. (2023). Understanding Synergistic Effects Between Corrosion Inhibitor Molecules Using Density Functional Theory. Transactions of Indian National Academy of Engineering. 8(3). 403–409.
7.
Mandal, Jajati, Vinay Jain, Sudip Sengupta, et al.. (2023). Determination of bioavailable arsenic threshold and validation of modeled permissible total arsenic in paddy soil using machine learning. Journal of Environmental Quality. 52(2). 315–327. 14 indexed citations
8.
Jain, Vinay, Divyashri Baraniya, Tsute Chen, et al.. (2023). Integrative Metatranscriptomic Analysis Reveals Disease-specific Microbiome–host Interactions in Oral Squamous Cell Carcinoma. Cancer Research Communications. 3(5). 807–820. 10 indexed citations
9.
Bhattad, Pradnya Brijmohan & Vinay Jain. (2020). Artificial Intelligence in Modern Medicine – The Evolving Necessity of the Present and Role in Transforming the Future of Medical Care. Cureus. 12(5). e8041–e8041. 41 indexed citations
10.
Toprani, Sneh M., et al.. (2019). Quantitation of genome damage and transcriptional profile of DNA damage response genes in human peripheral blood mononuclear cells exposed in vitro to low doses of neutron radiation. Iranian Journal of radiation research. 17(1). 1–14. 9 indexed citations
11.
Jain, Vinay, et al.. (2019). Restoration of a partially edentulous patient with combination partial dentures. BDJ. 226(6). 407–410. 3 indexed citations
12.
Maan, Sushila, et al.. (2018). Comparative evaluation of immunochromatographic and reverse transcriptase polymerase chain reaction based tests for diagnosis of canine distemper.. Intas Polivet. 19(2). 414–418. 2 indexed citations
14.
Sethi, Sumit, et al.. (2012). An in vitro investigation to compare the surface roughness of auto glazed, reglazed and chair side polished surfaces of Ivoclar and Vita feldspathic porcelain. The Journal of Indian Prosthodontic Society. 13(4). 478–485. 14 indexed citations
16.
DeGrendele, Heather & Vinay Jain. (2003). The Anti-HER2 Monoclonal Antibody Pertuzumab May Be Effective in Androgen-Independent Prostate Cancer. PubMed. 2(3). 143–145. 6 indexed citations
17.
Jain, Vinay, et al.. (2003). Crystal structure of tris(perfluorophenyl)bismuthine hemi-dioxane solvate, Ci8Fi5Bi·0.5C4H8O2. Zeitschrift für Kristallographie - New Crystal Structures. 218(JG). 69–70. 1 indexed citations
18.
Piro, Lawrence D., Christine A. White, A.J. Grillo-López, et al.. (1999). Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma. Annals of Oncology. 10(6). 655–661. 308 indexed citations
19.
McLaughlin, Peter, A.J. Grillo-López, Brian K. Link, et al.. (1998). Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.. Journal of Clinical Oncology. 16(8). 2825–2833. 2153 indexed citations breakdown →
20.
Jain, Vinay. (1996). [26] Vectors with bidirectional reporter genes for studying divergent promoters. Methods in enzymology on CD-ROM/Methods in enzymology. 273. 319–331. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026